Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto D'Angelo

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|August 8, 2018
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancerNavid Sobhani, Daniele Generali, Alberto D'Angelo, et al.
Biochemistry and Biophysics Reports|March 2, 2023
Corrigendum to "Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytes"Alberto D'Angelo, Kensuke Shibata, Masayuki Tokunaga, et al.
Expert Review of Clinical Pharmacology|May 13, 2020
Cabozantinib as a second-line treatment option in hepatocellular carcinomaAlberto D'Angelo, Navid Sobhani, Stefan Bagby, et al.
Biochemistry and Biophysics Reports|October 14, 2022
Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytesAlberto D'Angelo, Kensuke Shibata, Masayuki Tokunaga, et al.
Expert Review of Clinical Pharmacology|September 16, 2020
Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we standAlberto D'Angelo, Stefan Bagby, Ilaria Camilla Galli, et al.
World Journal of Clinical Oncology|September 30, 2025
Antibody-drug conjugates in metastatic urothelial cancer: Highway to heavenAlberto D'Angelo, Martina Catalano, Irene De Gennaro Aquino, et al.
International Immunopharmacology|October 1, 2024
Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathwaysMohammad Rasouli, Mana Alavi, Alberto D'Angelo, et al.
Lung|April 3, 2023
Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic PlatformRobert Chapman, Luke Jones, Alberto D'Angelo, et al.
International Journal of Molecular Sciences|January 16, 2020
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-AnalysisGiandomenico Roviello, Silvia Paola Corona, Alberto D'Angelo, et al.
Cancers|February 11, 2023
Current State and Future Challenges for PI3K Inhibitors in Cancer TherapyMarianna Sirico, Alberto D'Angelo, Caterina Gianni, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|August 8, 2018
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancerNavid Sobhani, Daniele Generali, Alberto D'Angelo, et al.
Biochemistry and Biophysics Reports|March 2, 2023
Corrigendum to "Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytes"Alberto D'Angelo, Kensuke Shibata, Masayuki Tokunaga, et al.
Expert Review of Clinical Pharmacology|May 13, 2020
Cabozantinib as a second-line treatment option in hepatocellular carcinomaAlberto D'Angelo, Navid Sobhani, Stefan Bagby, et al.
Biochemistry and Biophysics Reports|October 14, 2022
Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytesAlberto D'Angelo, Kensuke Shibata, Masayuki Tokunaga, et al.
Expert Review of Clinical Pharmacology|September 16, 2020
Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we standAlberto D'Angelo, Stefan Bagby, Ilaria Camilla Galli, et al.
World Journal of Clinical Oncology|September 30, 2025
Antibody-drug conjugates in metastatic urothelial cancer: Highway to heavenAlberto D'Angelo, Martina Catalano, Irene De Gennaro Aquino, et al.
International Immunopharmacology|October 1, 2024
Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathwaysMohammad Rasouli, Mana Alavi, Alberto D'Angelo, et al.
Lung|April 3, 2023
Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic PlatformRobert Chapman, Luke Jones, Alberto D'Angelo, et al.
International Journal of Molecular Sciences|January 16, 2020
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-AnalysisGiandomenico Roviello, Silvia Paola Corona, Alberto D'Angelo, et al.
Cancers|February 11, 2023
Current State and Future Challenges for PI3K Inhibitors in Cancer TherapyMarianna Sirico, Alberto D'Angelo, Caterina Gianni, et al.
Pageof 6